Jascindra Ravi

Title: Jascindra Ravi: Innovator in Cyclic Peptide Technology

Introduction

Jascindra Ravi is a notable inventor based in Teddington, GB. He has made significant contributions to the field of peptide technology, particularly with his innovative work on cyclic peptides. His research focuses on creating structures that can mimic biological environments, which has important implications for cell growth and biofilm resistance.

Latest Patents

Jascindra Ravi holds a patent for a cyclic peptide that includes two domains, each comprising three charged sub-domains. The first domain consists of two anionic sub-domains followed by a cationic sub-domain. The second domain features two cationic sub-domains followed by an anionic sub-domain. These domains are interconnected and separated by a tri-glycyl linker. This cyclic peptide is capable of self-assembling into a network that mimics an extracellular matrix, promoting cell growth while resisting biofilm formation. He has 1 patent to his name.

Career Highlights

Jascindra Ravi is associated with NPL Management Limited, where he applies his expertise in peptide technology. His work has garnered attention for its potential applications in biomedical fields, particularly in tissue engineering and regenerative medicine.

Collaborations

Jascindra has collaborated with notable colleagues, including Maxim Ryadnov and Nilofar Faruqui, who share his passion for advancing peptide research.

Conclusion

Jascindra Ravi's innovative work in cyclic peptide technology showcases his commitment to advancing scientific knowledge and practical applications in the field. His contributions are paving the way for future developments in biomedical research.